IL-17 and IL-22 in atopic allergic disease

Current Opinion in Immunology

Volumn 22, Issue 6, 2010, Pages 821-826

  Souwer, Yuri ^a   Szegedi, Krisztina ^a   Kapsenberg, Martien L ^a   De Jong, Esther C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CHEMOKINE RECEPTOR CCR10; CORTICOSTEROID; CUTANEOUS T CELL ATTRACTING CHEMOKINE; FILAGGRIN; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8;

ALLERGIC ASTHMA; ATOPIC DERMATITIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG MECHANISM; HELPER CELL; HUMAN; IMMUNOPATHOGENESIS; LYMPHOCYTE FUNCTION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; TH17 CELL; TH2 CELL; TH22 CELL; THERAPY RESISTANCE;

HUMANS; HYPERSENSITIVITY, IMMEDIATE; INTERLEUKIN-17; INTERLEUKINS;

EID: 78649850406     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2010.10.013     Document Type: Review

References (50)

1. Kolls J.K., Linden A. Interleukin-17 family members and inflammation. Immunity 2004, 21:467-476.
2. Chen Z., Laurence A., Kanno Y., Pacher-Zavisin M., Zhu B.M., Tato C., Yoshimura A., Hennighausen L., O'Shea J.J. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc Natl Acad Sci USA 2006, 103:8137-8142.
3. McGeachy M.J., Cua D.J. Th17 cell differentiation: the long and winding road. Immunity 2008, 28:445-453.
4. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 Cells. Annu Rev Immunol 2009, 27:485-517.
5. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 6:1133-1141.
6. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., Weaver C.T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 6:1123-1132.
7. Allen S.J., Crown S.E., Handel T.M. Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol 2007, 25:787-820.
8. Nograles K.E., Zaba L.C., Guttman-Yassky E., Fuentes-Duculan J., Suarez-Farinas M., Cardinale I., Khatcherian A., Gonzalez J., Pierson K.C., White T.R., et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol 2008, 159:1092-1102.
9. Tesmer L.A., Lundy S.K., Sarkar S., Fox D.A. Th17 cells in human disease. Immunol Rev 2008, 223:87-113.
10. Pene J., Chevalier S., Preisser L., Venereau E., Guilleux M.H., Ghannam S., Moles J.P., Danger Y., Ravon E., Lesaux S., et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 2008, 180:7423-7430.
11. Eyerich K., Pennino D., Scarponi C., Foerster S., Nasorri F., Behrendt H., Ring J., Traidl-Hoffmann C., Albanesi C., Cavani A. IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response. J Allergy Clin Immunol 2009, 123:59-66.
12. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240.
13. Wakashin H., Hirose K., Iwamoto I., Nakajima H. Role of IL-23-Th17 cell axis in allergic airway inflammation. Int Arch Allergy Immunol 2009, 149(Suppl. 1):108-112.
14. Dumoutier L., Louahed J., Renauld J.C. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol 2000, 164:1814-1819.
15. Wolk K., Kunz S., Witte E., Friedrich M., Asadullah K., Sabat R. IL-22 increases the innate immunity of tissues. Immunity 2004, 21:241-254.
16. Guttman-Yassky E., Lowes M.A., Fuentes-Duculan J., Zaba L.C., Cardinale I., Nograles K.E., Khatcherian A., Novitskaya I., Carucci J.A., Bergman R., et al. Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis. J Immunol 2008, 181:7420-7427.
17. Wolk K., Witte E., Witte K., Warszawska K., Sabat R. Biology of interleukin-22. Semin Immunopathol 2010, 32:17-31.
18. Nograles K.E., Zaba L.C., Shemer A., Fuentes-Duculan J., Cardinale I., Kikuchi T., Ramon M., Bergman R., Krueger J.G., Guttman-Yassky E. IL-22-producing " T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 2009, 123:1244-1252.
19. Duhen T., Geiger R., Jarrossay D., Lanzavecchia A., Sallusto F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 2009, 10:857-863.
20. Trifari S., Kaplan C.D., Tran E.H., Crellin N.K., Spits H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 2009, 10:864-871.
21. Geboes L., Dumoutier L., Kelchtermans H., Schurgers E., Mitera T., Renauld J.C., Matthys P. Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. Arthritis Rheum 2009, 60:390-395.
22. Boniface K., Bernard F.X., Garcia M., Gurney A.L., Lecron J.C., Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 2005, 174:3695-3702.
23. Zenewicz L.A., Yancopoulos G.D., Valenzuela D.M., Murphy A.J., Karow M., Flavell R.A. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 2007, 27:647-659.
24. Wenzel S.E., Szefler S.J., Leung D.Y., Sloan S.I., Rex M.D., Martin R.J. Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997, 156:737-743.
25. Ivanov S., Linden A. Th-17 cells in the lungs?. Expert Rev Respir Med 2007, 1:279-293.
26. Bullens D.M., Truyen E., Coteur L., Dilissen E., Hellings P.W., Dupont L.J., Ceuppens J.L. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?. Respir Res 2006, 7. 135.
27. Molet S., Hamid Q., Davoine F., Nutku E., Taha R., Page N., Olivenstein R., Elias J., Chakir J. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001, 108:430-438.
28. Zhao Y., Yang J., Gao Y.D., Guo W. Th17 immunity in patients with allergic asthma. Int Arch Allergy Immunol 2010, 151:297-307.
29. Schnyder-Candrian S., Togbe D., Couillin I., Mercier I., Brombacher F., Quesniaux V., Fossiez F., Ryffel B., Schnyder B. Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med 2006, 203:2715-2725.
30. Finkelman F.D., Hogan S.P., Hershey G.K., Rothenberg M.E., Wills-Karp M. Importance of cytokines in murine allergic airway disease and human asthma. J Immunol 2010, 184:1663-1674.
31. Wilson R.H., Whitehead G.S., Nakano H., Free M.E., Kolls J.K., Cook D.N. Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness. Am J Respir Crit Care Med 2009, 180:720-730.
32. Hellings P.W., Kasran A., Liu Z., Vandekerckhove P., Wuyts A., Overbergh L., Mathieu C., Ceuppens J.L. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Respir Cell Mol Biol 2003, 28:42-50.
33. Song C., Luo L., Lei Z., Li B., Liang Z., Liu G., Li D., Zhang G., Huang B., Feng Z.H. IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J Immunol 2008, 181:6117-6124.
34. Finotto S., Neurath M.F., Glickman J.N., Qin S., Lehr H.A., Green F.H., Ackerman K., Haley K., Galle P.R., Szabo S.J., et al. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 2002, 295:336-338.
35. Durrant D.M., Gaffen S.L., Riesenfeld E.P., Irvin C.G., Metzger D.W. Development of allergen-induced airway inflammation in the absence of T-bet regulation is dependent on IL-17. J Immunol 2009, 183:5293-5300.
36. Peng J., Yang X.O., Chang S.H., Yang J., Dong C. IL-23 signaling enhances Th2 polarization and regulates allergic airway inflammation. Cell Res 2010, 20:62-71.
37. McKinley L., Alcorn J.F., Peterson A., Dupont R.B., Kapadia S., Logar A., Henry A., Irvin C.G., Piganelli J.D., Ray A., et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol 2008, 181:4089-4097.
38. Schnyder B., Lima C., Schnyder-Candrian S. Interleukin-22 is a negative regulator of the allergic response. Cytokine 2010, 50:220-227.
39. De Benedetto A., Agnihothri R., McGirt L.Y., Bankova L.G., Beck L.A. Atopic dermatitis: a disease caused by innate immune defects?. J Invest Dermatol 2009, 129:14-30.
40. Hamid Q., Boguniewicz M., Leung D.Y. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994, 94:870-876.
41. Bieber T. Atopic dermatitis. N Engl J Med 2008, 358:1483-1494.
42. Toda M., Leung D.Y., Molet S., Boguniewicz M., Taha R., Christodoulopoulos P., Fukuda T., Elias J.A., Hamid Q.A. Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. J Allergy Clin Immunol 2003, 111:875-881.
43. Koga C., Kabashima K., Shiraishi N., Kobayashi M., Tokura Y. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 2008, 128:2625-2630.
44. Milner J.D., Brenchley J.M., Laurence A., Freeman A.F., Hill B.J., Elias K.M., Kanno Y., Spalding C., Elloumi H.Z., Paulson M.L., et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 2008, 452:773-776.
45. Palmer C.N., Irvine A.D., Terron-Kwiatkowski A., Zhao Y., Liao H., Lee S.P., Goudie D.R., Sandilands A., Campbell L.E., Smith F.J., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006, 38:441-446.
46. Weidinger S., Rodriguez E., Stahl C., Wagenpfeil S., Klopp N., Illig T., Novak N. Filaggrin mutations strongly predispose to early-onset and extrinsic atopic dermatitis. J Invest Dermatol 2007, 127:724-726.
47. Oyoshi M.K., Murphy G.F., Geha R.S. Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen. J Allergy Clin Immunol 2009, 124:485-493.
48. Howell M.D., Kim B.E., Gao P., Grant A.V., Boguniewicz M., Debenedetto A., Schneider L., Beck L.A., Barnes K.C., Leung D.Y. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 2007, 120:150-155.
49. Homey B., Alenius H., Muller A., Soto H., Bowman E.P., Yuan W., McEvoy L., Lauerma A.I., Assmann T., Bunemann E., et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 2002, 8:157-165.
50. Onoue A., Kabashima K., Kobayashi M., Mori T., Tokura Y. Induction of eosinophil- and Th2-attracting epidermal chemokines and cutaneous late-phase reaction in tape-stripped skin. Exp Dermatol 2009, 18:1036-1043.